AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 13 filers reported holding AKARI THERAPEUTICS PLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $38,000 | -35.6% | 15,000 | -50.0% | 0.00% | – |
| Q2 2018 | $59,000 | +7.3% | 30,000 | 0.0% | 0.00% | – |
| Q1 2018 | $55,000 | -57.7% | 30,000 | 0.0% | 0.00% | – |
| Q4 2017 | $130,000 | +5.7% | 30,000 | +50.0% | 0.00% | – |
| Q3 2017 | $123,000 | +284.4% | 20,000 | +185.7% | 0.00% | – |
| Q2 2017 | $32,000 | – | 7,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 178,091 | $703,459 | 0.52% |